Next-Generation Sequencing Company Sets Sights on $100 Genome Analysis – OncLive


OncLive

Next-Generation Sequencing Company Sets Sights on $100 Genome Analysis
OncLive
Illumina, which is based in San Diego, California, said its new NovaSeq series sequencers are designed so that researchers can conduct large-scale genomics projects with greater sample volumes, thus lowering the per-sample costs for most applications.
Here's Why the Best Is Yet to Come for Illumina, Inc.Madison.com

all 2 news articles »

Source: Genome Sequencing